Deep Dive Into Valvoline Stock: Analyst Perspectives (4 Ratings)
Mar 19, 2024 · News for Valvoline; Deep Dive Into Valvoline Stock: Analyst Perspectives (4 Ratings) ... Deep Dive Into Valvoline Stock: Analyst Perspectives (4 Ratings) Benzinga. Mar. …
OFF
Deep Dive Into Vale Stock: Analyst Perspectives (4 Ratings)
6 hours from now
Nov 11, 2024 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $14.5, a high estimate of $16.00, and a low estimate of $11.50.
benzinga.com
OFF
Deep Dive Into Lamar Advertising Stock: Analyst Perspectives (4 …
6 hours from now
Nov 11, 2024 · Analysts have recently evaluated Lamar Advertising and provided 12-month price targets. The average target is $137.75, accompanied by a high estimate of $160.00 and a low …
benzinga.com
OFF
Deep Dive Into Nike Stock: Analyst Perspectives (33 Ratings)
6 hours from now
Nov 18, 2024 · Analysts have recently evaluated Nike and provided 12-month price targets. The average target is $89.7, accompanied by a high estimate of $110.00 and a low estimate of …
nasdaq.com
OFF
Keros Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 ...
6 hours from now
Nov 22, 2024 · Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $87.25, with a high estimate of $100.00 and a low estimate …
benzinga.com
OFF
Deep Dive Into Summit Materials Stock: Analyst Perspectives
6 hours from now
3 days ago · Deep Dive Into Summit Materials Stock: Analyst Perspectives (11 Ratings) ... Diving into Analyst Ratings: An In-Depth Exploration ... With an ROE of 2.4%, the company may face …
benzinga.com
OFF
Eagle Materials Stock: A Deep Dive Into Analyst Perspectives
6 hours from now
4 days ago · Analysts have set 12-month price targets for Eagle Materials, revealing an average target of $316.4, a high estimate of $330.00, and a low estimate of $290.00.
nasdaq.com
OFF
TG Therapeutics Stock: A Deep Dive Into Analyst Perspectives
6 hours from now
4 days ago · In the assessment of 12-month price targets, analysts unveil insights for TG Therapeutics, presenting an average target of $43.8, a high estimate of $55.00, and a low …
nasdaq.com
OFF
Deep Dive Into NovoCure Stock: Analyst Perspectives (4 Ratings)
6 hours from now
Oct 16, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $28.0, a high estimate of $40.00, and a low estimate of …
nasdaq.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension